SCHEMBL20467598

SCHEMBL20467598

C=C(C=N)c1cccc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 2/20 0.50
▸ CES1 P23141 2/20 0.50
▸ PARP1 P09874 1/20 0.47
▸ PTGS1 P23219 2/20 0.45
▸ PTGS2 P35354 2/20 0.45
▸ HDAC1 Q13547 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44
▸ PLA2G7 Q13093 1/20 0.40
▸ NFE2L2 Q16236 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ KCNK3 O14649 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ GPR52 Q9Y2T5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12831681 0.82 CES2 (0.52) CES2CES1PARP1PTGS1PTGS2
SCHEMBL13059672 0.80 CES2 (0.55) CES2CES1PARP1PTGS1PTGS2
SCHEMBL24914456 0.77 CES2 (0.47) CES2CES1PARP1PTGS1PTGS2
SCHEMBL28863383 0.76 CES2 (0.60) CES2CES1PARP1PTGS1PTGS2
SCHEMBL24711143 0.76 PARP1 (0.47) PARP1HDAC6MEN1KMT2ASMN1; SMN2
SCHEMBL16603073 0.76 CES2 (0.61) CES2CES1PARP1HDAC1HDAC6
SCHEMBL18962593 0.74 CES2 (0.48) CES2CES1PARP1PTGS1PTGS2
SCHEMBL29327905 0.74 CES2 (0.58) CES2CES1PARP1PTGS1PTGS2
SCHEMBL12919933 0.73 AKT1 (0.41) CES2CES1PARP1MEN1KMT2A
SCHEMBL18962686 0.73 PARP1 (0.48) CES2CES1PARP1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10383861-B2 3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof Sammumed, LLC (US) 2019-08-20 — — US disclosed
US-20180221351-A1 3-(1H-PYRROLO[2,3-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINES AND THERAPEUTIC USES THEREOF MED-PATHWAYS II LIMITED (VG) 2018-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10383861-B2 3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof WNT3, WNT1, WNT3A CES2 4862/4885CES1 3996/4885PARP1 617/4885
US-20180221351-A1 3-(1H-PYRROLO[2,3-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINES AND THERAPEUTIC USES THEREOF WNT3, WNT1, WNT3A CES2 4862/4885CES1 3996/4885PARP1 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback